Flexijoint 3-in-1 Joint Care Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Per tab Glucosamine HCl 500 mg, chondroitin sulfate 400 mg, methylsulfonylmethane 300 mg. Per sachet Glucosamine HCl 1,500 mg, chondroitin sulfate 1,200 mg, methylsulfonylmethane 900 mg

Indications/Uses

Adjuvant therapy for OA.

Click to view Flexijoint 3-in-1 Joint Care detailed prescribing information

Dosage/Direction for Use

Adult Tab Light or moderate OA symptoms 1 tab bd for at least 6 wk. Severe OA symptoms 1 tab tds for at least 8-12 wk. Maintenance 1 tab bd for 3-4 mth, may be repeated every other ≤6 mth. Powd for oral soln 1 sachet once daily.

Click to view Flexijoint 3-in-1 Joint Care detailed prescribing information

Overdosage

View Flexijoint 3-in-1 Joint Care overdosage for action to be taken in the event of an overdose.

Administration

Should be taken on an empty stomach.

Contraindications

Hypersensitivity. Not to be given to patients allergic to shellfish.

Click to view Flexijoint 3-in-1 Joint Care detailed prescribing information

Special Precautions

Exclude presence of other joint conditions/diseases. Closely monitor blood glucose levels in patients w/ higher HbA1c levels or taking insulin. Severe hepatic or renal insufficiency. Avoid use during 1st trimester of pregnancy. Lactation. Avoid use in childn.

Click to view Flexijoint 3-in-1 Joint Care detailed prescribing information

Use In Pregnancy & Lactation

Click to view Flexijoint 3-in-1 Joint Care detailed prescribing information

Adverse Reactions

Peripheral oedema, tachycardia; skin reactions eg, erythema, pruritus.

Click to view Flexijoint 3-in-1 Joint Care detailed prescribing information

Drug Interactions

Impaired insulin secretion. Increased insulin resistance. Affected glucose tolerance. Reduced antidiabetic effects of acarbose, acetohexamide, chlorpropamide, glipizide, glyburide, metformin, miglitol, pioglitazone, repaglinide, rosiglitazone, glimepiride, tolbutamide, troglitazone. Reduced effectiveness of doxorubicin, etoposide, teniposide. Potentiated anticoagulant effects of warfarin. Powd for oral soln: Formed complexes w/ chitosan.

Click to view Flexijoint 3-in-1 Joint Care detailed prescribing information

Storage

View Flexijoint 3-in-1 Joint Care storage conditions for details to ensure optimal shelf-life.

Description

View Flexijoint 3-in-1 Joint Care description for details of the chemical structure and excipients (inactive components).

Action

View Flexijoint 3-in-1 Joint Care mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Other Drugs Acting on Musculo-Skeletal System

ATC Classification

M01AX05 - glucosamine ; Belongs to the class of other non-steroidal antiinflammatory and antirheumatic products.
M09AX - Other drugs for disorders of the musculo-skeletal system ; Used in the treatment of musculo-skeletal disorders.

Regulatory Classification

Presentation/Packing

Form

Flexijoint 3-in-1 Joint Care powd for oral soln

Packing/Price

(orange flavour, sugar-free) 5.5 g x 30 × 1's

Form

Flexijoint 3-in-1 Joint Care tab

Packing/Price

30's;60's

Flexijoint 3-in-1 Joint Care

Manufacturer:

Winwa Medical

Distributor:

Winwa Medical